PepRank

N-Acetyl Semax Amidate

Also: NA-Semax-Amidate · NASA

EnergyMoodNasal / Injection

Stabilised, stronger, longer-acting Semax; same use (focus, mental energy).

Safety tier
Caution
strict bar
Positive
55%
of 48 reports
Per month
≈ €4.8–14
nasal
Rank
#6
of 61 research peptides

At a glance

Access
Grey market
NasalFelt in 15–30 min
Lasts 6–8 h
Best effects
Stronger, longer focus than plain Semax · uplifted mood · mental calm for monotonous work · stimulant potentiation
Downsides
Lethargy or 'too much espresso' discomfort at higher doses · post-use low mood/anhedonia in a few reports · vivid dreams · headache
Typical use
100-300 mcg/day (lower than plain Semax); short courses. Users report 300–800 mcg/day (median 450 mcg, n=5).
Stacked with
Stacked with
NA-Selank-Amidate: The most common pairing, both taken in the morning; Selank is meant to blunt the anxiety and irritability NA-Semax can bring. · Caffeine, modafinil or methylphenidate: Users say it amplifies stimulants noticeably; several end up cutting their caffeine because of it. · Bromantane: Popular on r/NooTopics for drive and motivation; reported as a good pairing, without trial data.

Safety

Tier by safety barStrict CautionBalanced CautionEvidence only Clean
  • Seen harm0 of 3
  • Mechanism1 of 3
  • Data gap3 of 3
  • Silent harm1 of 3
  • Product2 of 3
Never if
Pregnancy or breastfeeding (no human reproductive data)
Why each score
Seen harm 0/3
Around fifty first-hand reports include low mood, brain fog and one depressive dip from day three, but nothing reaching emergency care or lasting harm. This zero reflects community use only: no study has looked. r/NooTopics: NA-Semax gave serious depression and anhedonia from day three ↗
Mechanism 1/3
The same active sequence as Semax with both ends capped to slow breakdown, so it inherits Semax's speculative neurotrophin effect; the only comparison paper found acetylation changes copper binding in vitro, which is not a harm path. Magrì et al. 2016: N-terminal acetylation changes Semax's copper binding and biological properties (PubMed 27586814) ↗Dolotov et al. 2006: Semax raises BDNF and trkB in rat hippocampus (PubMed 16996037) ↗
Data gap 3/3
No human, animal toxicology or pharmacokinetic data exist for the modified molecule; Semax's Russian trials bridge only partly, because capping is meant to make it stronger and longer-acting. Magrì et al. 2016: N-terminal acetylation changes Semax's copper binding and biological properties (PubMed 27586814) ↗Semax 0.1% official Russian prescribing information (reg. LS-002553) ↗
Silent harm 1/3
Reported effects (irritability, low mood, fog) are noticed within a day or two and fade on stopping.
Product 2/3
Sold only by research-chemical vendors as premixed nasal sprays or vials; a few inject it. Mendias & Awan 2026 preprint: 6,441 grey-market peptide samples, 42-71% failed quality criteria, 15% had endotoxin ↗

User reports

All 53 reports →
Users report
Users who like Semax often prefer the NA/amidate form (stronger mood lift, longer). But overdosing is easier: lethargy, discomfort above ~300 mcg, and a few reports of a crash into low mood or anhedonia after 2-3 days. Around 30-40% still report nothing.
Glowing 3Positive 24Mixed 4Nothing 12Negative 4Bad reaction 1
  • @sahil_harriram· · 6 likesOriginal ↗

    N-Acetyl Semax Amidate was by far the best nootropic i've had. Its a shame its so hard to source :(

    Glowing

  • @__tux· · 2 likesOriginal ↗

    i’m only a week on it, but it’s nothing short of incredible for me rn. tldr: - N-Acetyl Semax Amidate is best - intranasal, 300mcg - once every morning, maybe twice ymmv

    Glowing300 mcg each morning · Nasal · 1 week

  • @emilylai· · 29 likesOriginal ↗

    I was interested in cognitive benefits like recall, memory, and focus ... Unlike GLPs or NAD+, I didn’t feel immediate effects with these

    NothingNasal

    tried Semax, NA Semax Amidate, Adamax and Adalank

Where to buy

All 19 offers →
Getting it
Sold only by research-chemical vendors as pre-mixed nasal sprays or vials; no approved or compounded version.

A month at 100–300 mcg/day costs ≈ €4.8–14 from Semax Polska at €1.59/mg, a blend, since no pure pack is listed. At the 300–800 mcg/day users report, ≈ €14–38.

Cheapest from trusted shops in the EU

ShopPackPricePer mgPer monthTesting
Semax PolskaEU · PL
Trust 4/5Each product shows an Analiza Białek (Wrocław) HPLC report naming its operator Dobre Peptydy sp. z o.o. as the client, with a verification password (Semax 60 mg: 62.18 mg, 99%), and Reddit buyers since 2024 report fast, professional deliveries; the only complaints are about felt effect.Ships to France for €14, 1–5 days.COAs ↗
spray · 20 mg⚠ +5 mg GHK-Cu arginateAvoid€32€1.59/mg≈ €4.8–14 a monthThird-party tested

Studies

Evidence
No studies of its own — For the modified form (parent Semax is approved in Russia)
Caveat
Acetylation/amidation of the same sequence; no specific harm path, but no clinical or tox data on the modified molecule and grey-market only. Rated slightly below Semax for that reason.
2 more studies and 2 sources

Sources

Molecule

Sequence
MEHFPGP
Length
7 amino acids
Modifications
N-acetyl, C-amide

Sequence

The peptide's chain of amino acids from its start (the N-terminus) to its end, one bead and one letter for each: A alanine, C cysteine, D aspartic acid, E glutamic acid, F phenylalanine, G glycine, H histidine, I isoleucine, K lysine, L leucine, M methionine, N asparagine, P proline, Q glutamine, R arginine, S serine, T threonine, V valine, W tryptophan, Y tyrosine. A modification such as an N-acetyl cap or a C-terminal amide changes how long it lasts in the body. Length tells related peptides apart, from a two-residue dipeptide like carnosine to a 43-residue protein like thymosin beta-4, and predicts neither effect nor safety.

Report grades

Every first-hand Reddit or X report is graded on its own, from glowing through positive, mixed, nothing and negative to bad reaction, and the bar shows how those grades split. Posts that look vendor-adjacent stay on the peptide's page but are left out of the counts.

GlowingPositiveMixedNothingNegativeBad reaction

% positive

The share of a peptide's graded Reddit and X reports that are glowing or positive, vendor-adjacent posts left out. A peptide with few reports is pulled toward the average of all reports, as if it had eight average ones besides its own, so two glowing posts cannot top the list. Peptides rank by this figure, those with no graded report yet after those with one, and Avoid ones after every other entry.

Researcher estimate

No first-hand report of this peptide has been graded yet, so the figure is the researchers' own rating out of 10 from what they read about it. It ranks after every peptide with graded reports until its own arrive.

Safety tier

Each peptide is tiered Clean, Caution or Avoid from its five risk axes under the chosen safety bar. An Avoid peptide carries a real risk of harm, a plausible route to serious harm rather than mere unpleasantness, so it stays listed with the reason but ranks behind every other entry, however good its reviews.

Safety bar

The safety bar sets how much risk it takes to rate a peptide Avoid. Strict: out on any serious mechanism with little human data, or any documented serious harm. Balanced: out on documented serious harm (unless it is obvious, reversible and from a regulated product), or a serious mechanism whose harm would be silent with no human data at all. Evidence only: out only on documented serious harm in humans that is lasting, delayed or from grey-market product.

Seen harm

Documented serious adverse events in humans, from 0 for none despite real exposure to 3 for deaths or several well-documented serious harms. Serious means a hospital or emergency visit or harm lasting weeks, so a headache or a bad night does not count.

Mechanism

A plausible biological route to serious harm at the doses people use, such as growth-factor signalling, hormone-axis suppression, heart or blood-pressure effects or immune activation. It runs from 0 when none is known to 3 when a dangerous pathway has been shown in living animals.

Data gap

How little human safety data exists for the molecule actually sold, from 0 for an approved drug with large trials and years of use to 3 for no human safety data at all. A modified analogue does not inherit its parent's trials.

Silent harm

Whether the feared harm would show quickly or stay hidden, from 0 when it is obvious and goes on stopping to 3 when it is silent and delayed, like tumour promotion or slow organ damage. User reports cannot reveal a harm that takes years to appear, so a high score here limits what good reviews can tell you.

Product

The risk of what people actually buy, from 0 for a regulated pharmacy or supplement product taken by mouth or on the skin to 3 for a grey-market injectable. In one dataset of 6,441 grey-market samples, 42–71% failed basic quality criteria and 15% carried endotoxin; taken by mouth or in the nose, a pack avoids the injection risks.

Evidence

The strongest kind of study behind the peptide's effects, from an approved drug through human controlled trials and small human studies to animal work or nothing of its own. Animal results often fail to carry over to people.

Access

How people get it: as an approved drug, a compounded prescription, an over-the-counter supplement or from the grey market, where nobody checks the vial. The channel decides both the legal position and the risk of a bad batch.

Price per month

Thirty days of the typical dose, from its low end to its high end, priced at the listing a careful buyer would choose: in stock, from a shop scoring 4 of 5 on trust (third-party tested where no score is set), failing that 3, a pure pack before a blend, a European shop first, then the cheapest per mg. The range is the dose's, not the shops'. A per-dose amount counts once a day unless the dose says otherwise. Prices are in euros at ECB rates of 2026-10-29, before shipping; the shop table keeps each listing's price per mg, per gram for bulk supplements. Where no listing can be priced the researchers' own estimate stands in, and says so.

Dose users report

The middle half of the daily doses stated in at least five first-hand reports, vendor posts left out. Where its middle sits more than twice above or below the declared dose, the month is priced at it as well, since what people take is what they pay for.

Shop trust

Each shop's trust on a 1–5 scale, read from its testing and its reputation: 1 for serious red flags (fabricated COAs, scam reports, impersonation, a closed shop), 2 for no public testing, a new shop or active complaints such as seized parcels, 3 for its own COAs or a short track record, 4 for verified third-party testing or a strong reputation, and 5 for third-party batch reports that name the shop, with years of good independent reputation. A shop without a score counts third-party batch testing as 4, its own COAs as 3 and no public tests as 2.

Best value

Within a category or a goal, a peptide that no other beats on both counts: none is rated more positively for the same or a lower monthly price, and none costs less for the same or a higher rating. The chart joins these into the best-value line; the cheapest of them and the best-rated of them both make it, so the line spans the trade-off from cheap to best. Avoid entries never count, and a peptide needs both a % positive and a price to be compared.

Testing

Whether the shop publishes lab results: third-party tested means an independent lab checks each batch, own COA means the shop's own certificate of analysis, and no public tests means neither. A certificate shows purity, not safety.

Added peptide

Some packs sold under one peptide's name hold a second one, such as 5 mg GHK-Cu in a nasal kit, stated only in the description. Sprayed in the nose or injected it reaches the blood like an injection, so it carries the risk of that route and is tiered as the injectable form, whatever its tier on the skin. A pack whose page gives no contents list may hold more than its name.